Odisha’s COVID-19 caseload crosses 17,000-mark; death toll mounts to 91

By: |
Published: July 19, 2020 1:55 PM

Of the 736 new cases, 481 were reported from quarantine centres, while the remaining 255 were contacts of COVID-19 patients, the official said.

Odisha, covid 19 cases in odisha, Odisha,covid 19 death toll in odisha, COVID-19 patients, Ganjam, latest news on coronavirus outbreakOf the 736 new cases, 481 were reported from quarantine centres, while the remaining 255 were contacts of COVID-19 patients, the official said. (Representational image: IE)

Odisha’s COVID-19 caseload crossed the 17,000-mark on Sunday with 736 more people testing positive for the infection, while five fresh fatalities pushed the death toll due to the disease in the state to 91, a health official said.

The fresh cases reported from 25 districts have taken the state’s COVID-19 tally to 17,437, he added. Of the 736 new cases, 481 were reported from quarantine centres, while the remaining 255 were contacts of COVID-19 patients, the official said.

The state had registered its highest single-day spike of 755 COVID-19 cases on July 10. Three of the five fresh fatalities were reported from Ganjam, the worst-hit district in the state. Sundergarh and Jagatsinghpur reported a death each, the official said.

Besides, two COVID-19 patients died due to other ailments, taking the number of such fatalities in Odisha to 28, he added.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Covid recovery rate rises to 70.77%, record 8.3 lakh tests conducted in 24 hours – Latest updates
2Coronavirus on food packaging: China finds virus traces in Brazilian chicken wings, Ecuadorian shrimp packs
3Africa begins continent-wide study of COVID-19 antibodies